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Ectopic expression of the transcription factors Oct4,
Sox2, c-Myc, and Klf4 in fibroblasts generates in-
duced pluripotent stem (iPS) cells. Little is known
about the nature and sequence of molecular events
accompanying nuclear reprogramming. Using doxy-
cycline-inducible vectors, we have shown that exog-
enous factors are required for about 10 days, after
which cells enter a self-sustaining pluripotent state.
We have identified markers that define cell popula-
tions prior to and during this transition period. While
downregulation of Thy1 and subsequent upregula-
tion of SSEA-1 occur at early time points, reactivation
of endogenousOct4, Sox2, telomerase, and the silent
X chromosome mark late events in the reprogram-
ming process. Cell sorting with these markers allows
for a significant enrichment of cells with the potential
to become iPS cells. Our results suggest that factor-
induced reprogramming is a gradual process with
defined intermediate cell populations that contain
the majority of cells poised to become iPS cells.
INTRODUCTION
Nuclear reprogramming allows the study of the nature and re-
versibility of genomic modifications that are imposed on cells
during differentiation and development (Hochedlinger and Jae-
nisch, 2006). In addition, the reprogramming of adult cells into
embryonic stem (ES) cells enables the generation of patient-spe-
cific stem cells and thus has enormous potential for the treat-
ment and analysis of degenerative diseases (Yamanaka, 2007).
Reprogramming can be achieved by nuclear transfer into oo-
cytes (Wakayama et al., 1998; Wilmut et al., 1997), by cell fusion
between ES cells and somatic cells (Cowan et al., 2005; Tada
et al., 2003), and by the ectopic expression of transcription
factors in somatic cells (Takahashi et al., 2007; Takahashi and
Yamanaka, 2006; Yu et al., 2007). In the latter approach, viral230 Cell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc.expression of the transcription factors Oct4 and Sox2, combined
with Klf4 and c-Myc (Maherali et al., 2007; Okita et al., 2007; Park
et al., 2008; Takahashi et al., 2007; Wernig et al., 2007) or Lin28
and Nanog (Yu et al., 2007), generates iPS cells from mouse and
human fibroblast cultures.
iPS cells were initially isolated using drug selection for the re-
activation of ES cell-specific genes, including Fbx15 (Takahashi
and Yamanaka, 2006), Oct4, or Nanog (Maherali et al., 2007;
Okita et al., 2007; Wernig et al., 2007). Curiously, iPS cells pro-
duced with Fbx15 selection were less potent than ES cells, while
iPS cells produced with either Oct4 or Nanog selection appeared
functionally and molecularly indistinguishable from ES cells, sug-
gesting that Fbx15 is a less stringent selection marker than Oct4
andNanog. The similarity between iPS cells and ES cells and the
ease with which iPS cells can be generated compared with nu-
clear transfer or cell fusion make this approach a powerful tool
for further studying the process of nuclear reprogramming and
for potential clinical applications. Indeed, iPS cells have recently
been shown in a proof-of-principle experiment to treat sickle cell
anemia in mice (Hanna et al., 2007).
Little is known about the molecular and cellular events accom-
panying nuclear reprogramming. The generation of iPS cells
from fibroblasts is a gradual process that takes between 15
and 20 days upon infection of somatic cells with retroviruses ex-
pressing Oct4, Sox2, Klf4, and c-Myc, giving rise to iPS cells at
a frequency of less than 0.1% (Maherali et al., 2007; Takahashi
and Yamanaka, 2006; Wernig et al., 2007). Omission of c-Myc
from the reprogramming cocktail further reduces the efficiency
and delays the process (Nakagawa et al., 2008; Wernig et al.,
2008). Established iPS cells show silencing of retroviral genes
and the re-expression of endogenous pluripotency genes such
asOct4 andNanog (Maherali et al., 2007; Okita et al., 2007; Wer-
nig et al., 2007). Moreover, iPS cells reactivate the silenced X
chromosome in female cells, restore telomerase activity, and
re-establish a genome-wide histone methylation pattern charac-
teristic of ES cells (Maherali et al., 2007; Takahashi and Yama-
naka, 2006). It is not known, however, whether these events
take place in a sequential order and which events coincide
with the time point when somatic cells become independent of
exogenous factor expression. These questions could not be fully
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tively active viruses expressing the reprogramming factors had
been used. We have therefore generated a doxycycline-induc-
ible viral system, which allows temporal control of factor ex-
pression, and have used it to reprogram fibroblasts harboring
reporters for pluripotency genes and retroviral gene activity.
With these reagents, we have determined the temporal require-
ment for the four factors and have defined molecular corner-
stones during the reprogramming of fibroblasts into iPS cells.
Our results provide the basis for attempts to replace viral gene
delivery systems with small compounds or protein transduction
systems and a platform for further dissecting the mechanisms of
nuclear reprogramming.
RESULTS
Temporal Requirement for Exogenous Factor
Expression during In Vitro Reprogramming
of Fibroblasts
To generate an inducible system for factor-mediated reprogram-
ming of fibroblasts into iPS cells, we created doxycycline-con-
trolled lentiviral vectors by replacing the ubiquitin promoter of
FUGW (Lois et al., 2002) with a tetOP sequence, followed by
the coding regions for Oct4, Sox2, c-Myc, and Klf4, respectively
(Figure 1A). The majority of fibroblasts containing an optimized
reverse tetracycline transactivator driven off the constitutively
expressed ROSA26 promoter (R26-M2rtTA) (Hochedlinger
et al., 2005) that were infected with a GFP-carrying variant of
this virus became GFP+ within 12–24 hr after doxycycline admin-
istration, thus validating the system (see Figure S1 available
online). R26-M2rtTA heterozygous fibroblasts with a knockin of
GFP into the endogenous Oct4 locus (Oct4-GFP) (Lengner
et al., 2007) were infected with viruses containing the four re-
programming factors. Two days after the addition of doxycycline
to the culture medium, morphological changes were seen in
infected fibroblast cultures, and microcolonies appeared 1 day
later, which by day 6 had grown into large colonies of loosely at-
tached cells (Figures 1B–1D). By day 9, tightly packed colonies
that were weakly GFP+ were seen (Figures 1E and 1F). When
picked and cultured in the absence of doxycycline, these cells
gave rise to strongly GFP+ colonies that grew into stable iPS lines
and had the potential to contribute to all germ layers in chimeric
animals (Figure 1G and data not shown). These observations
demonstrate the functionality of our inducible lentiviral system
to produce bona fide iPS cells.
To determine the temporal requirement for the four transcrip-
tion factors during reprogramming, infected fibroblasts were
treated with doxycycline for up to 13 days to induce factor
expression, followed by doxycycline withdrawal and culture in
standard ES cell medium until day 20, when the total number
of iPS colonies was scored based on morphology and GFP ex-
pression (Figure 1H). Colonies that formed in cultures treated
with doxycycline for 7 days or less consistently regressed within
48 hr of doxycycline withdrawal, indicating that no stably reprog-
rammed cells were present until that time point (Figure 1I and
data not shown). However, fibroblasts treated with doxycycline
for 8 or more days gave rise to colonies that continued to grow
in the absence of doxycycline and formed clearly visible iPS
clones that homogeneously expressed GFP at day 20 (Figures1J and 1K). At days 8 and 9, the frequency of cells that gave
rise to stably reprogrammed iPS colonies at day 20 was about
0.016%. Addition of doxycycline until day 10 increased this fre-
quency 4-fold to 0.06%, while only a modest increase in the
number of iPS colonies was seen thereafter (Figure 1I). Efficien-
cies were determined based on the theoretical number of cells
infected with all four viruses (Takahashi and Yamanaka, 2006),
which we calculated to be 40%. The vast majority of colonies
scored at day 20 were GFP+, had an ES-like morphology, and
could be expanded into stable lines, whereas all GFP colonies
had a differentiated morphology and could not be expanded
(Figures 1L and 1M). These results show that reprogramming is
a gradual process that requires the expression of the four factors
for at least 8 days before cells begin to enter a stable self-
sustaining pluripotent state.
Surface Markers Thy1 and SSEA-1 Distinguish Early
Intermediates of the Reprogramming Process
In order to further characterize subpopulations of cells before
and after they become doxycycline independent, we used flow
cytometry to follow the change in expression of the surface anti-
gens Thy1, which is expressed at high levels on fibroblasts and
other differentiated cell types (Rege and Hagood, 2006), and
SSEA-1, which is expressed on ES cells (Cui et al., 2004).
FACS analysis showed that the majority (70%–80%) of cells
in untreated fibroblast cultures were Thy1+, while no SSEA-1 ex-
pression above background levels could be detected (Figure 2A).
Established iPS cells, on the other hand, were uniformly Thy1
and predominantly SSEA-1+ (Figure 2A). The observed small
fraction of SSEA-1 iPS cells (10%) reflects heterogeneous
expression of this marker, which is consistent with previous
observations in undifferentiated ES cells (Cui et al., 2004).
To start with a cell population homogeneous for Thy1 expres-
sion, we FACS sorted Thy1+ fibroblasts to purity (Figure 2B) and
infected them with inducible lentiviruses. In the absence of doxy-
cycline, these cells stably maintained a Thy1+SSEA-1 pheno-
type in culture (Figure 2C). In contrast, 3 days of doxycycline
induction resulted in the downregulation of Thy1 expression in
about a third of the cells (Figure 2D). No SSEA-1+ cells could
be detected at this time point. At day 5, roughly half of the cul-
tured cells shut down Thy1 expression and a small fraction of
Thy1 cells activated SSEA-1 expression (1%–5% of total cells).
By day 7, about 70% of cells had become Thy1 and about 5%–
10% of total cells showed an SSEA-1+Thy1 phenotype. This
pattern did not significantly change until day 12, when doxycy-
cline was withdrawn from the cultures. One week after doxycy-
cline withdrawal, however, an SSEA-1highThy1 population
was detected, which likely represented successfully reprog-
rammed and hence doxycycline-independent cells that had
expanded. The observation that the number of Thy1SSEA-1
cells was greatly reduced at this time compared to day 12 sug-
gested that most of the Thy1SSEA-1 cells represent an unsta-
ble reprogramming intermediate. Collectively, these data indi-
cate that Thy1 downregulation is an early event during the
reprogramming process that occurs in the majority of cells. A
subset of Thy1 cells then initiates SSEA-1 expression, first at
low and eventually at high levels. Figure 2F summarizes the
reciprocal pattern of Thy1 downregulation and SSEA-1 upregu-
lation during the reprogramming of purified Thy1+ fibroblasts.Cell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc. 231
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Kinetics of Fibroblast to iPS Cell ReprogrammingFigure 1. Development of a Doxycycline-Inducible Lentiviral System and Assessment of the Temporal Requirement for Reprogramming
Factors
(A) Schematic drawing of the inducible lentivirus containing a doxycycline-controllable promoter (tetOP-CMV) and a unique EcoRI restriction site to insert cDNAs.
(B–E) Morphology of infected Oct4-GFP tail-tip fibroblasts cultured with doxycycline for 0, 3, 6, and 9 days. Arrow in (C) indicates a microcolony.
(F) GFP fluorescence image of colonies shown in (E). Note weakly GFP+ colony (outlined in green) with smooth borders next to a GFP colony with differentiated
appearance (outlined in red).
(G) Three-week-old coat color chimera generated from blastocyst injection of iPS cells made with inducible lentiviruses shown left of a nonchimeric littermate.
(H) Experimental outline to determine temporal requirement of reprogramming factors. Fibroblasts heterozygous for ROSA26-rtTA and Oct4-GFP alleles were
infected with the four lentiviruses (LV), doxycycline (dox) was added for a period of 0–13 days, and GFP+ iPS colonies were scored on day 20.
(I) Effect of duration of doxycycline expression on the number of GFP+ (green bars) and GFP (red bars) colonies present at day 20.
(J–M) Bright-field and fluorescence images of a representative GFP+ iPS colony (J and K) as well as a GFP- differentiated colony (L and M) at day 20.232 Cell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc.
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Kinetics of Fibroblast to iPS Cell ReprogrammingFigure 2. Kinetics of Thy1 and SSEA-1 Surface Antigen Expression during Reprogramming
(A) FACS plots showing Thy1 and SSEA-1 expression in an established iPS line, respectively.
(B and C) (B) FACS plot of Thy1+ fibroblasts immediately after sorting and (C) after lentiviral infection and culture in the absence of doxycycline for 16 days,
demonstrating sort purity and stability of Thy1 expression in the absence of viral gene expression.
(D) Representative FACS plots of Thy1 and SSEA-1 expression in infected fibroblasts on days 1, 3, 5, 7, 9, and 12 after doxycycline induction, showing the gradual
downregulation of Thy1 and upregulation of SSEA-1.
(E) FACS plot of infected fibroblasts cultured for 12 days in the presence of doxycycline and analyzed at 7 days postwithdrawal (12+7). Note the emergence of an
SSEAhighThy1 population resembling the phenotype of stable iPS cells shown in (A).
(F) Summary of kinetic changes of Thy1 and SSEA-1 expression, indicating the fractions of Thy1+SSEA-1, Thy1SSEA-1, and SSEA-1+Thy1 cells. Voltage
settings of the FACS analyzer were not identical between (A) and (C–E), leading to slight differences in the appearances of the depicted populations. Error bars
indicate range of marker-positive cells in two independent experiments.Reactivation of Pluripotency Genes, Telomerase,
and the Silent X Chromosome Are Late Events
in the Reprogramming Process
Successfully reprogrammed cells show reactivation of endoge-
nous pluripotency genes and the silent X chromosome (Maher-
ali et al., 2007; Okita et al., 2007; Wernig et al., 2007) and
express telomerase (Takahashi and Yamanaka, 2006). We
tested whether activation of these markers occurs early or
late during the reprogramming process and determined how
they intersect with the kinetics of SSEA-1 upregulation. To
this end, we FACS sorted Thy1+ fibroblasts isolated from
mice carrying GFP reporters for Sox2 (Ellis et al., 2004), mTert
(Armstrong et al., 2000; D.T.B., I.M. Min, D.L. Carlone, L.G. Far-illa, D.E. Henderson, S. Algra, R.K. Montgomery, A.J. Wagers,
and N. Hole, unpublished data), or the silent X chromosome
(X-GFP) (Hadjantonakis et al., 1998) and infected them with in-
ducible lentiviruses. Female X-GFP fibroblasts were presorted
by FACS for GFP cells in which the GFP-carrying X chromo-
some had been inactivated. Established iPS cells showed
strong expression of Sox2 and mTert and reactivation of the
silent X chromosome (Figures 3A–3F). Both the mTert-GFP
and X-GFP transgenes, however, had heterogeneous expres-
sion patterns similar to ES cells (data not shown), possibly
due to transgene silencing, loss of the transgene-carrying chro-
mosome (Robertson et al., 1983), or heterogeneity of ES cells
(Chambers et al., 2007).Cell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc. 233
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Kinetics of Fibroblast to iPS Cell ReprogrammingFigure 3. Timing of Sox2-GFP, mTert-GFP, and X-GFP Reactivation during Reprogramming
(A–F) Bright-field and GFP images of iPS cells derived from Sox2-GFP (A and B), mTert-GFP (C and D), and X-GFP (E and F) fibroblasts. The dotted circle in (F)
indicates a colony entirely GFP, possibly due the loss of one X chromosome.
(G) Experimental outline to determine temporal relationship of SSEA-1 expression, GFP marker activation, and the appearance of doxycycline-independent iPS
cells. Fibroblasts from the different GFP reporter lines were infected with the inducible lentiviruses, cultured in the presence of doxycycline for 10–12 days, and
then split equally into two fractions: one fraction was immediately analyzed by flow cytometry, and another fraction was analyzed after 7 days of culture without
doxycycline.
(H–J) FACS plots showing GFP and SSEA-1 expression in the cultures at the time of doxycycline withdrawal (upper panels) and at 7 days postwithdrawal (lower
panels). Sox2-GFP cells were analyzed with a FACSAria, while mTert-GFP and X-GFP cells were analyzed with a FACSCalibur.234 Cell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc.
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fected fibroblasts were cultured for 10–12 days in the presence
of doxycycline, at which time no GFP+ colonies could be de-
tected by microscopic examination (data not shown). The cul-
tures were then harvested and split into two fractions
(Figure 3G). The first fraction was analyzed immediately by
flow cytometry for GFP and SSEA-1 expression, which revealed
a significant number of SSEA-1+ cells, and a lack of GFP+ cells in
the mTert-GFP and X-GFP cultures, with rare SSEA-1+GFP+
cells being detectable in the Sox2-GFP cultures (Figures 3H–
3J, upper panels). The other fraction was analyzed in a similar
manner at 7 days after withdrawal of doxycycline. At that time,
SSEA-1+GFP+ cells were readily detectable in all reporter lines
(Figures 3H–3J, lower panels). As expected from the micro-
scopic inspection of doxycycline-independent iPS colonies
(Figures 3A–3F), some SSEA-1+ cells were negative for mTert-
GFP and X-GFP, respectively. These observations indicate that
reactivation of the pluripotency transcription factor Sox2, the
silenced X chromosome, and telomerase are late events during
the reprogramming process and correlate with the time period
when cells start to become independent of doxycycline and
thus exogenous factor expression.
Retroviral Silencing Is a Gradual Process
that Is Completed in Established iPS Cells
One of the characteristics of pluripotent cells that distinguishes
them from somatic cells is their ability to silence retroviruses
(Barklis et al., 1986; Teich et al., 1977) by de novo DNA methyl-
ation (Okano et al., 1999) and other mechanisms (Wolf and Goff,
2007). Consistent with this observation, faithfully reprogrammed
cells show silencing of the retroviral Oct4, Sox2, c-myc, and Klf4
genes (Maherali et al., 2007; Okita et al., 2007; Wernig et al.,
2007), whereas partially reprogrammed cells show incomplete
silencing and persistent expression of the viral factors (Takaha-
shi and Yamanaka, 2006).
To determine the kinetics of retroviral silencing, we infected fi-
broblasts carrying the Sox2-GFP reporter with a pMX retrovirus
expressing the red fluorescent protein tdTomato (short ‘‘To-
mato’’). Thy1+Tomato+ cells were FACS sorted (Figure S2A), in-
fected with lentiviruses, induced with doxycycline, and analyzed
at different time points for the percentages of Tomato+ cells
(Figure 4A). We focused on four different populations, represent-
ing different stages of the reprogramming process: Thy1+ fibro-
blasts, Thy1SSEA-1 early intermediate cells, SSEA-1+Thy1
GFP late intermediate cells, and SSEA-1+Thy1GFP+ cells, in
which Sox2-GFP expression had just become detectable
(Figure S2B). Flow cytometric analyses of the four different pop-
ulations at day 14 (Figure 4B) showed >80% Tomato labeling in
the Thy1+ fibroblast fraction, consistent with strong viral activity
and a low degree of silencing, which was comparable to that of
infected fibroblasts grown in the absence of doxycycline (Fig-
ure S2D). Early intermediate cells contained roughly 50% To-
mato-positive cells, while only 20% of the late intermediate cells
and less than 5% of GFP+SSEA-1+ cells retained retroviral gene
expression at day 14. FACS analysis at different time points after
induction confirmed these observations, showing stable viral
gene expression in the Thy1+SSEA-1 population, 50% silenc-
ing in the Thy1SSEA-1 fraction, and progressive silencing in
the SSEA-1+Thy1GFP and SSEA-1+ Thy1GFP+ populations(Figure 4C). In agreement with these observations, microscopic
inspection of individual colonies derived from SSEA-1+Tomato
+GFP cells isolated by FACS from day 8 cultures and imaged
after 5 additional days in culture in the presence of doxycycline
showed speckled patterns of Tomato+GFP cells, where silenc-
ing had not yet occurred, and TomatoGFP+ cells, where suc-
cessful silencing and concomitant reactivation of the Sox2 locus
had occurred. Tomato/GFP double-positive cells were never
observed (Figures 4D and 4E).
To test whether the early silencing of retroviruses may be due
to the upregulation of de novo methyltransferases or other
known silencing factors, we examined the expression of
Dnmt3a, Dnmt3b (Okano et al., 1999), and TRIM28 (Wolf and
Goff, 2007) by quantitative RT-PCR. All three genes showed dy-
namic expression patterns, with Dnmt3a levels peaking at day 3
in the Thy1 fraction and Dnmt3b and TRIM28 levels gradually
increasing with highest expression in Oct4-GFP+ cells at day
13 (Figure S2). Together, these results argue that retroviral si-
lencing is a gradual process that is initiated early but completed
late in the reprogramming process, coinciding with the activation
of epigenetic regulators and pluripotency genes.
Identification of Cell Populations with Increased
Reprogramming Potential by Marker Gene Expression
The observation that surface and genetic markers identify phe-
notypic intermediates of the reprogramming process implies
that the marked cell populations should have different potentials
to give rise to iPS cells. To test this notion, we FACS sorted dif-
ferent populations from lentivirally infected fibroblasts at days 3,
8, and 13 after induction based on the expression of Thy1, SSEA-
1, and either Sox2-GFP (day 8) or Oct4-GFP (days 3 and 13) (see
Figures S3A–S3C for gating logic) and plated equal numbers of
cells in the presence of doxycycline. As outlined in Figure 5A,
doxycycline was withdrawn from all cultures at day 13 and iPS
colonies were scored at day 20. The kinetics of Sox2-GFP and
Oct4-GFP activation during reprogramming were similar and
will therefore only be referred to as GFP. At day 3, all cells with
iPS-forming potential were found in the Thy1 fraction, which
was calculated to be enriched 3.3-fold over an equal number
of unfractionated cells (Figure 5B and Figure S3D). By day 8,
most cells with iPS-forming potential had moved into the
SSEA-1+Thy1 fraction, which had a 20-fold enrichment of
iPS-forming cells over the total population. At day 13, cells
with the highest iPS-forming potential had shifted from the
SSEA-1+Thy1 fraction to the SSEA-1+GFP+ fraction and
showed a 5-fold enrichment of iPS-forming cells over total cells.
The low enrichment of iPS-forming cells in the latter fraction
compared with the SSEA-1+ fraction at day 8 is due to a signifi-
cant expansion of GFP+ cells in the total culture, thus lowering
the overall enrichment.
These results show that the combination of surface markers
and reporters allows for a prospective enrichment for cells with
the potential to become iPS cells. The observation that the frac-
tion of cells with the highest iPS-forming potential changes over
time suggests that the phenotype of reprogramming cells moves
in a linear fashion from an early Thy1 phenotype via an interme-
diate SSEA-1+ phenotype to a late Oct4+/Sox2+ phenotype,
which is closest to the final reprogrammed state. To determine
the cellular phenotype, which is indicative of cells that haveCell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc. 235
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(A) Experimental outline. Tail fibroblasts heterozygous for ROSA26-M2rtTA and Sox2-GFP alleles were infected with pMX retrovirus expressing the fluorescent
protein tdTomato (RV-tdTomato). Thy1+Tomato+ cells were purified by FACS, infected with the four lentiviral factors, cultured in the presence of doxycycline, and
reanalyzed by FACS at the indicated time.
(B) FACS histograms showing the percentages of Tomato+ cells in fibroblasts (Thy1+) and intermediate populations (Thy1-SSEA-1, SSEA-1+GFP and
SSEA-1+GFP+) 14 days after viral induction.
(C) Percentages of Tomato+ cells in fibroblasts and infected subpopulations in the same subpopulations shown in (B) but analyzed at different time points after
induction. ND (not determined) indicates lack of that cell population at the respective time point.
(D and E) Bright-field image and GFP/Tomato overlay of an early iPS colony that formed after sorting SSEA-1+Tomato+Thy1GFP cells at day 8 and seeding
them on feeder cells at clonal density. Note the speckled pattern and lack of overlap between Sox2-GFP and retroviral Tomato expression.reached a self-sustaining pluripotent state, we cultured the dif-
ferent populations sorted at day 13 for another 3 days in the
presence of doxycycline before doxycycline withdrawal. As
shown in Figure 6A, colonies were scored at day 20 and results
were compared with those obtained after immediate doxycy-
cline withdrawal at day 13 (see Figure 5B). We consistently de-
tected more colonies in the fractions that were treated with doxy-
cycline for 16 days compared with fractions treated for only 13
days (Figures 6B and 6C). However, there was a significant236 Cell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc.difference in the ratio of doxycycline-dependent versus doxycy-
cline-independent colonies, depending on the cellular pheno-
type. For example, extension of the doxycycline treatment
from day 13 to day 16 increased the numbers of colonies ob-
tained from the Thy1 population 15-fold, from the SSEA-
1+GFP fraction 3- to 4-fold and from the SSEA-1+GFP+ fraction
2-fold (Figure 6C), indicating that there are qualitative differ-
ences in the reprogramming status of the individual populations,
with Thy1 cells being the least reprogrammed population and
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compared to the plating efficiency of established iPS cells, how-
ever, day 13 GFP+ cells were still about 60% less efficient in mak-
ing iPS colonies in the absence of doxycycline, while addition of
doxycycline almost closed this gap (20% for GFP+ cells versus
30% for iPS cells).
To further characterize the different intermediate populations
at the molecular level, we analyzed the expression of candidate
fibroblast- and ES cell-specific markers (Figure 5C). Consistent
with the early downregulation of Thy1 expression, we observed
rapid reduction in the levels of the fibroblast genes Col5a2 and
Fibrillin2 in the Thy1 fraction at day 3, which were further down-
regulated in later fractions. Conversely, expression of the ES
cell-specific marker Fbx15 became weakly detectable by day 3
and was further increased in the day 9 Thy1 and day 13
SSEA-1+GFP fractions before being massively upregulated in
the SSEA-1+GFP+ fraction by day 13. This is in contrast toNanog
and Oct4 expression, which became detectable only at around
day 9. Esrrb was strongly expressed only in the SSEA-1+GFP+
fraction, at similar levels as seen in established iPS cells. The ob-
servation that the day 13 SSEA-1+GFP+ fraction expresses lower
levels of Oct4 and Nanog than established iPS cells might
Figure 5. Phenotypically Defined Sub-
populations Have Different iPS-Forming
Potentials
(A) Experimental outline. Different subpopulations
of cells, defined by the expression of Thy1, SSEA-
1, and Oct4-GFP or Sox2-GFP, were FACS sorted
from fibroblast cultures at the indicated times after
factor induction and seeded at equal numbers
onto feeder cells. Doxycycline was withdrawn at
day 13, and doxycycline-independent GFP+ colo-
nies were scored at day 20.
(B) Seeding efficiencies of the different subfrac-
tions and of unfractionated cultures sorted at the
indicated time points are plotted as percentages
of sorted cells that formed iPS colonies at day
20. Data from two independent experiments are
shown.
(C) Graphs showing expression levels of candidate
fibroblast (col5a2 and Fibrillin2) and ES cell
(Fbx15, Oct4, nanog, and Esrrb) markers by
qPCR relative to GAPDH. D, day; ND, not deter-
mined; S+G, SSEA-1+GFP; S+G+, SSEA-
1+GFP+; Thy, Thy1SSEA-1. Error bars indicate
one standard deviation.
explain the lower plating efficiency of
the former cells and suggests that the
pluripotent transcriptome is further fine-
tuned after the initial reactivation of pluri-
potency genes.
DISCUSSION
We have generated a doxycycline-induc-
ible lentiviral system to transiently ex-
press the four reprogramming factors
c-Myc, Klf4, Oct4, and Sox2 in fibro-
blasts. iPS cells produced with this sys-
tem are pluripotent and give rise to chimeras when injected into
blastocysts, similar to retrovirally produced iPS cells. We and
others have recently shown that drug selection is not required
to obtain iPS cells (Blelloch et al., 2007; Maherali et al., 2007;
Meissner et al., 2007). However, omission of drug selection in-
creases the number of false positive colonies, such as trans-
formed cells or cells that failed to receive all four viruses, and ne-
cessitates a trained eye to identify ES cell-like colonies. A major
advantage of the inducible system over constitutive expression
systems is that it allows for the ‘‘self-selection’’ of reprogrammed
cells in the absence of drug selection and obviates the need for
ES cell expertise. After stably reprogrammed cells have been
generated and doxycycline has been withdrawn, cells that sur-
vive go on to reactivate the endogenous pluripotency program,
while unstable reprogramming intermediates and transformed
colonies disappear, likely through differentiation or apoptosis.
We have used the doxycycline-dependent system to assess
the temporal requirement for exogenous factor expression to
produce iPS cells. Our results show that the four factors are
required for only about 10 days, at which point the somatic
genome becomes poised for conversion into a pluripotent state.
This has been consistently seen in independent experimentsCell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc. 237
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reprogramming follows a defined rather than a random se-
quence of molecular events that transform a differentiated cell
into a pluripotent cell. In agreement with this notion, we have
identified and characterized cell populations that appear prior
to and during this transition point by surface marker expression,
reporter gene activity, and transcriptional analyses (Figure 7).
Based on these results, we conclude that downregulation of fi-
broblast markers such as Thy1 is the earliest detectable change
in cells undergoing reprogramming, followed by modest activa-
tion of the ES cell marker SSEA-1, which is further upregulated at
the time when cells become doxycycline independent. At this
transition point, other major modifications take place, including
the reactivation of Oct4 and Sox2, telomerase, and the silenced
X chromosome. Importantly, reactivation of these markers is not
Figure 6. Correlation between Cellular Phenotype
and Degree of Reprogramming
(A) Experimental outline. Thy1+, Thy1SSEA-1, SSEA-1+
GFPThy1 as well as SSEA-1+GFP+Thy1 cells were
sorted from Oct4-GFP fibroblast cultures at day 13 after
factor induction. Twenty-five hundred cells from each
fraction were cultured either in the absence or presence
of doxycycline for another 3 days. Doxycycline-indepen-
dent GFP+ iPS colonies that had formed under either
condition were scored at day 20.
(B) Images of representative day 20 cultures stained with
alkaline phosphatase to demonstrate the colony-forming
ability of the different subfractions in the absence (upper
panel) or presence (lower panel) of doxycycline. A stable
iPS line that has been passaged several times is shown
for comparison.
(C) Graphic representation of the iPS-forming potential of
the different day 13 subpopulation in the absence (red) or
presence (green) of doxycycline, showing results from two
independent experiments for each condition. Percentages
above the bars indicate the fraction of colonies that
formed in the absence of doxycycline compared with the
fraction of colonies that formed in the presence of doxycy-
cline for the different subpopulations.
yet indicative of a fully reprogrammed pheno-
type because continuous expression of exoge-
nous factors can still increase the number of
iPS colonies. Interestingly, the ES cell-specific
Fbx15 gene is reactivated at day 3, before other
pluripotency genes, including Nanog, Oct4, and
Esrrb, become detectable. This may explain
why the initially derived iPS cells made with an
Fbx15 selectable allele (Takahashi and Yama-
naka, 2006) appeared incompletely reprog-
rammed compared with the subsequently
reported Nanog selection approach (Maherali
et al., 2007; Okita et al., 2007; Wernig et al.,
2007). Support for the functional importance of
the markers described here comes from the ob-
servation that FACS sorting of subpopulations
defined by these markers allows for a significant
enrichment for cells with the potential to be-
come iPS cells.
Retroviral silencing during reprogramming appears to be
a gradual process that occurs as early as 4 days after the induc-
tion of the transcription factors but is completed only in cells that
have reached the transition point of doxycycline independence.
In accordance with the observed early retroviral silencing is the
transient upregulation of the de novo methyltransferase Dnmt3a,
while silencing at later stages coincides with the upregulation of
Dnmt3b (Okano et al., 1999) and the retroviral silencing factor
TRIM28 (Wolf and Goff, 2007). This finding implies that the
frequency of obtaining iPS cells with retroviruses should be re-
duced due to premature silencing in some cells. Indeed, we
have observed that infection of fibroblasts with lentiviruses,
which are not subject to silencing, gives rise to ES-like colonies
roughly 5–10 times more efficiently compared with retroviruses
(M.S., N.M., and K.H., unpublished data).238 Cell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc.
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Kinetics of Fibroblast to iPS Cell ReprogrammingFigure 7. Kinetics of Marker Expression during ReprogrammingThe molecular mechanism underlying nuclear reprogramming
remains enigmatic. Due to its low efficiency, it has thus far been im-
possible to capture intermediate stages of the reprogramming pro-
cess. Our identification of intermediate cell populations that are en-
riched for iPS-producing cells will help to solve some of the open
questions surrounding nuclear reprogramming. For example, a ge-
nome-wideanalysisof individualsubpopulations at differentstages
of the reprogramming process will be instrumental for understand-
ing how the three or four transcription factors induce pluripotency
and epigenetic reprogramming. Lastly, the system described
here provides the framework for the identification of genes and
chemicals that replace or enhance the production of iPS cells.
EXPERIMENTAL PROCEDURES
Viral Production
A tet-inducible lentivirus called LV-tetO was generated by removing the EcoRI/
PacI fragment containing the ubiquitin promoter elements from the FUDGW
vector (Lois et al., 2002) (modified from FUGW by removal of GFP with
EcoRI-XbaI and re-creation of the EcoRI site) and replacing it with tetO
sequences derived from pTet-Splice by EcoRI/XhoI digestion. cDNAs for
c-Myc (T58A mutant), Klf4, Oct4, and Sox2 were isolated from pMIG or pMX
vectors and cloned into LV-tetO using a unique EcoRI restriction site. To pro-
duce infectious viral particles, 293T cells cultured on 10 cm dishes were trans-
fected with the LV-tetO vectors together with the packaging plasmids VSV-G
and D8.9 using Fugene (Roche). To generate RV-tdTomato, the BamHI/NotI
fragment from pIRES-tdTomato (a kind gift of Dr. Niels Geijsen) was cloned
into the EcoRI site of pMX (Morita et al., 2000) and transfected into 293T cells
together with packaging plasmids PCG-ori-gagpol and PCG-ori-VSVG using
Fugene. Viral supernatants were harvested on 3 consecutive days starting
24 hr after transfection, concentrated by centrifugation at 20,000 rpm for
1.5 hr at 4C, resuspended in PBS, and stored at 80C.
Flow Cytometry
Cultures were harvested by incubation in 0.25% trypsin/1 mM EDTA for 5 min
at 37C, and single-cell suspensions were obtained by repetitive pipetting and
transfer through a 40 mm cell strainer. Cells were incubated with PE-conju-
gated rat anti-Thy1 (53-2.1, eBiosciences) and unconjugated mouse anti-
SSEA-1 (MC-480, Developmental Hybridoma Bank) antibodies, followed by
incubation with APC-conjugated mouse anti-mouse IgM antibody (II/41, eBio-
sciences) and either analyzed on a FACSCalibur (BD Biosciences) or sorted/
analyzed on a FACSAria (BD Biosciences). For staining of pMX-tdTomato in-
fected cells, Thy1 expression was visualized by staining with biotinylated rat
anti-Thy1 antibody, followed by Pacific blue-conjugated streptavidin (Invitro-
gen). Dead cells were excluded by staining with either propidium iodide or
DAPI. Data were analyzed with FlowJo software (Tree Star).Generation of Sox2-GFP Reporter Mice
V6.5 ES cells were targeted with a Sox2-GFP knockin construct described
previously (Ellis et al., 2004). Linearized DNA was electroporated into ES cells,
colonies were selected with G418, and expanded clones were screened for
correct integration by standard Southern blot analysis. Correct clones were
injected into tetraploid blastocysts to produce entirely ES cell-derived mice
(Eggan et al., 2001).
Production of Chimeric Mice
Female BDF1 mice were superovulated with PMS and hCG and mated to
BDF1 stud males. Zygotes were isolated from females with a vaginal plug
24 hr after hCG injection. After 3 days of in vitro culture in KSOM media, blas-
tocysts were identified, injected with iPS cells, and transferred into pseudo-
pregnant recipient females. Pups were delivered by Cesarean section at day
19.5 and nurtured by foster mothers.
Fluorescence Microscopy
Cells were imaged using a Leica DMI4000B inverted fluorescence microscope
equipped with a Leica DFC350FX camera. Images were processed and
analyzed using Adobe Photoshop software.
RNA Isolation and qPCR
RNA was isolated from FACS-sorted cells using the RNeasy Plus Microkit, fol-
lowing the manufacturer’s instructions to use spin columns to exclude geno-
mic DNA, and cDNA was produced with the First Strand cDNA Synthesis Kit
(Roche). Real-time quantitative PCR reactions were set up in duplicate or trip-
licate with the Brilliant II SYBR Green QPCR Master Mix (Stratagene) and run
on an Mx3000P QPCR System (Stratagene). Primer sequences for qPCR were
taken from PrimerBank (http://pga.mgh.harvard.edu/primerbank/index.html)
(Wang and Seed, 2003) and are listed in Table S1.
Cell Culture
Fibroblasts were isolated from tail-tip biopsies of newborn (3–8 days of age)
Sox2-GFP/R26-M2rtTA, Oct4-GFP/R26-M2rtTA, and mTert-GFP mice as
well as from E14.5 female X-GFP/R26-M2rtTA embryos and expanded in fibro-
blast medium (DMEM with 10% FBS, L-glutamine, penicillin-streptomycin,
nonessential amino acids, and b-mercaptoethanol). Viral infections were usu-
ally carried out at passage 2 or 3 in 35 mm plates at a density of 200,000 fi-
broblasts/plate in fibroblast medium containing 5 mg/ml polybrene. mTert-GFP
fibroblasts were coinfected with a lentivirus constitutively expressing M2rtTA.
The infection media was replaced after 12–24 hr with ES medium (DMEM with
15% FBS, L-glutamin, penicillin-streptomycin, nonessential amino acids, b-
mercaptoethanol, and 1000 U/ml LIF) supplemented with 1 mg/ml doxycycline.
Fresh ES medium with doxycycline was added every 2–4 days until either col-
onies were picked, cultures were harvested for FACS analysis, or doxycycline
was withdrawn by completely aspirating the medium, washing twice with PBS,
and then continuing the culture in standard ES medium. Alkaline phosphatase
staining was performed using the Vector Red Substrate Kit (Vector Labs).Cell Stem Cell 2, 230–240, March 2008 ª2008 Elsevier Inc. 239
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